$327,127,680
to LEIDOS BIOMEDICAL RESEARCH INC
NCI OPERATIONAL TASK ORDER, FY26-FY27
Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.
What the model surfaced from this award
Operational task order funding for National Cancer Institute research activities and infrastructure for fiscal years 2026-2027.
NCI is the primary U.S. federal agency coordinating cancer research; this sustains critical infrastructure for drug discovery and clinical trials.
Supports demand for laboratory equipment, bioinformatics platforms, and contract research services from biotech supply chain vendors.
U.S. cancer research leadership depends on sustained federal funding to maintain competitive advantage in oncology therapeutics and precision medicine.
Generated by award_classification v1.0.0 via claude-haiku-4-5-20251001 on 2026-05-13. Cost: $0.001362.
- USAspending.gov — all awards for this UEI →
- SAM.gov entity registration →
- Award record ingested from usaspending. Source identifier CONT_AWD_75N91025F00016_7529_75N91019D00024_7529.
The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.